Case number 1:19-cv-01214
Eisai Co., Ltd. et al v. Glenmark Pharmaceuticals Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (6) |
| Aug 26, 2019 | 8 | SO ORDERED (3) Docket Text: SO ORDERED, re [7] CONSENT JUDGMENT, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 8/26/19. (ntl) |
| Aug 23, 2019 | 7 | Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT by Eisai Co., Ltd., Eisai Inc., Novartis Pharma AG. (Blumenfeld, Jack) |
| Jul 3, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:19-cv-01213-LPS, 1:19-cv-01214-LPS (rjb) |
| Jun 27, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Glenmark Generics Limited on 6/27/2019; Glenmark Pharmaceuticals Inc., USA on 6/27/2019; Glenmark Pharmaceuticals Limited on 6/27/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Jun 26, 2019 | 1 | Exhibit A (9) |
| Jun 26, 2019 | 1 | Civil Cover Sheet (1) |
| Jun 26, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jun 26, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/15/2019. Date of Expiration of Patent: 5/14/2023.Thirty Month Stay Deadline: 11/15/2021. (nmg) |
| Jun 26, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1. (nmg) |
| Jun 26, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Corporation of North America, Corporate Parent Eisai Co., Ltd. for Eisai Inc. filed by Eisai Inc. No Parents or Affiliates Listed filed by Eisai Co., Ltd. (nmg) |
| Jun 26, 2019 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharma AG filed by Novartis Pharma AG. (nmg) |
| Jun 26, 2019 | 1 | Main Document (6) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Glenmark Generics Limited, Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2673947.) - filed by Eisai Inc., Eisai Co., Ltd., Novartis Pharma AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg) |
| Jun 26, 2019 | 1 | Complaint* (1) |
